LLY Eli Lilly and Company
Company Analysis
Latest News
Eli Lilly Shares Decline Following Trump's Remarks on Weight-Loss Drug Pricing
Eli Lilly and Company (LLY) shares experienced a significant drop of over 4% in premarket trading on Friday, October 17, 2025. The decline followed comments...
Eli Lilly's Oral Weight-Loss Drug Orforglipron Succeeds in Late-Stage Diabetes Trials
Eli Lilly and Company (NYSE: LLY) announced on October 15, 2025, that its experimental oral GLP-1 drug, orforglipron, achieved its primary and key secondary...
Eli Lilly to Unveil Key Overall Survival Data for Verzenio at ESMO 2025
Eli Lilly and Company announced it will present new clinical data from its oncology portfolio at the European Society for Medical Oncology (ESMO) Annual...
Eli Lilly to Unveil Key Overall Survival Data for Breast Cancer Drug Verzenio at ESMO 2025
On October 13, 2025, Eli Lilly and Company announced it will present new clinical data from its oncology portfolio at the European Society for Medical Oncology...
Eli Lilly and Partner Roche Gain FDA Approval for Alzheimer's Blood Test
Eli Lilly and Company, in partnership with Roche, has received clearance from the U.S. Food and Drug Administration (FDA) for their blood test designed to aid...
Eli Lilly to Invest Over $1 Billion in India to Expand Manufacturing and Supply Chain
Eli Lilly and Company announced on October 6, 2025, a significant investment of over $1 billion into new contract manufacturing in India. The investment...
Eli Lilly to Invest Over $1 Billion in Indian Manufacturing Partnerships
Eli Lilly and Company announced it will invest over $1 billion in contract manufacturing partnerships in India to increase the global supply of its drugs for...